Understanding Kidney Cancer
- “Vanderpump Rules” star Jax Taylor, 47, has revealed that he was diagnosed with kidney cancer after a hospital visit for kidney stones led to a CT scan that uncovered a tumor on his left kidney.
- Taylor, who lost his father to cancer, underwent a five-hour surgery to remove the tumor, which was larger than doctors expected, and is now awaiting pathology results.
- Kidney cancer often causes no symptoms in its early stages, and many cases are found by chance during imaging for an unrelated issue, just as Taylor’s was. When caught early, kidney cancer is highly treatable.
- If you’re facing a cancer diagnosis, it’s important to lean on your support system and ask your doctor questions so you understand your treatment options and next steps.
- If you’re experiencing symptoms and are unaware of the cause, get trusted, doctor-reviewed answers instantly with SurvivorNet’s AI-powered “My Health Questions.”
In a heartfelt Instagram post, the father of one shared that a hospital visit for kidney stones led to a CT scan that uncovered a tumor on his left kidney.
Read More“My CT scan also showed a tumor on my left kidney. After many tests and appointments I found out it was cancer.”
View this post on Instagram
Taylor, whose real name is Jason Cauchi, was an original cast member when the show premiered in 2013. He later starred in the spinoff “The Valley” alongside his ex-wife, Brittany Cartwright, with whom he shares a son, Cruz.
For Taylor, his kidney cancer diagnosis carried an added emotional weight. “I lost my father to cancer, so hearing that word just broke me,” he shared. “It put me in a really dark place. The hardest part was the waiting. Knowing there was a tumor growing inside me while trying to go about my life like everything was fine.”
He added, “It’s crazy how you can act like everything is normal when deep down you’re a mess.”
RELATED: When Kidney Cancer Progresses After Immunotherapy: A New Treatment Option Offers Hope
Expert Resources On Kidney Cancer
The news came during an already transformative chapter in Taylor’s life. In 2024, he entered in-patient treatment for his mental health and later shared that he had been diagnosed with bipolar disorder and post-traumatic stress disorder (PTSD).
He has also spoken openly about his recovery from addiction to cocaine and alcohol. In his cancer post, Taylor noted that he will celebrate two years sober on November 28. “I’m so f—ing proud,” he wrote.
That stretch of uncertainty, from discovering a tumor to waiting on tests, surgery and results, is something many cancer patients know well. The anxiety that comes with it, sometimes called “scanxiety,” can take a real toll on mental health, and for those in recovery, a cancer diagnosis can add another layer of stress. Experts encourage patients to speak openly with their care team and loved ones about how they’re feeling, and to lean on the support systems that help them stay well.
Taylor underwent a five-hour surgery to remove the tumor and thanked his surgeon, Dr. Michael Adhoot, and the medical team at Cedars-Sinai.
He explained in his Instagram post, “The tumor has been removed but it was a lot larger than they thought so we are waiting on the pathology results.”
Stress and anxiety are common emotions that are experienced after a cancer diagnosis
Looking back, Taylor believes the painful kidney stone may have been a blessing in disguise, writing, “If I hadn’t ended up in the hospital with that kidney stone, I probably wouldn’t have known this tumor was there until it was too late. I like to think my dad had a part in that.”
His message to fans is a simple but powerful one: “If there’s one thing I hope people can take away from this, it’s never to take your health for granted.”
View this post on Instagram
Kidney Cancer Symptoms and Treatment
Kidney cancer affects tens of thousands of Americans each year, with about 80,450 new cases expected in 2026, according to the American Cancer Society. Renal cell carcinoma is the most common form, accounting for about 9 in 10 cases.
In the early stages, kidney cancer may not cause noticeable symptoms. However, what a patient experiences can differ widely depending on the tumor’s type, size, and location. Below are some potential symptoms and side effects that individuals with kidney cancer might encounter:
- Blood in the urine
- Lower back pain on one side
- Tiredness and fatigue
- Weight loss
- Reduced appetite
- Lumps or growths on the lower back or the side
- High temperature and fever that doesn’t seem to go away
- Anemia: low counts of red blood cells
Surgery is often the primary approach for treating kidney tumors, especially when the cancer is still localized, meaning it hasn’t spread (metastasized) to other parts of the body.
There are several types of surgical procedures used to treat kidney cancer, including:
- Radical nephrectomy
- Partial nephrectomy
- Cytoreductive nephrectomy
- Laparoscopic and robotic surgery
Treatment Options for Kidney Cancer: What You Should Know
Kidney cancer can be treated through a range of approaches—each designed to target cancer cells in different ways. Your care team will help determine the best path forward based on your diagnosis, overall health, and personal preferences. Here’s a breakdown of key treatment options:
- Radiofrequency Ablation (RFA): This minimally invasive procedure uses a needle inserted directly into the tumor. Electric currents and radiofrequency waves heat and destroy the cancerous tissue from within.
- Cryoablation: In this technique, extremely cold probes are placed into the tumor to freeze and kill cancer cells. It’s often used for small tumors or patients who aren’t candidates for surgery.
- Chemotherapy: Chemotherapy uses powerful medications to stop cancer cells from growing, dividing, or surviving. While kidney cancer is often resistant to traditional chemotherapy, certain drugs may be used in specific cases or in combination with other therapies.
- Radiation Therapy: Uses high-energy particles or waves to damage and destroy cancer cells. The two main types are:
- External Beam Radiation: Delivered from outside the body, targeting the tumor with precision.
- Internal Radiation (Brachytherapy): Places radioactive material directly inside or near the tumor.
- Immunotherapy: This innovative approach activates your immune system to better detect and attack cancer cells. Treatments like immune checkpoint inhibitors help the body overcome cancer’s defenses and mount a stronger response.
- Targeted Therapy: These drugs target specific genes or proteins that fuel cancer growth. One notable example is belzutifan (Welireg), approved by the FDA in August 2021 for patients with Von Hippel-Lindau (VHL) disease-related kidney cancers. Belzutifan blocks a protein called HIF-2α, which some kidney cancers use to adapt to low-oxygen conditions and activate genes that fuel tumor growth.
- Combination Therapy: In many cases, doctors may recommend a blend of treatments—such as immunotherapy paired with targeted therapy—to increase effectiveness and tailor care to your unique needs.
WATCH: Immunotherapy Needs to be Tailored
The Immunotherapy Offering Kidney Cancer Patients Hope
The immunotherapy drug Keytruda is approved to treat some types of kidney cancer. Keytruda is an immune checkpoint inhibitor, a type of immunotherapy that helps the immune system recognize and attack cancer cells. Its approval for use after surgery stemmed from the KEYNOTE-564 trial.
“The goal (of the study) was to see if (the drug) can prevent kidney cancer coming back,” Dr. Toni Choueiri, director of the Lank Center for Genitourinary Oncology at the Dana-Farber Cancer Institute and lead author of the study, tells SurvivorNet. (The study itself was supported by pharmaceutical company Merck & Co. and conceived by Dr. Choueiri and some co-authors.)
Keytruda was approved for the adjuvant treatment (additional cancer treatment given after the primary treatment) of patients with renal cell carcinoma at an intermediate-high or high risk of recurrence following nephrectomy, or following nephrectomy and resection (removal) of metastatic lesions.
RELATED: FDA Approval May Help Reduce the Risk of Kidney Cancer Returning After Surgery
New Treatment Options Offer Hope for Advanced Kidney Cancer
As of his post, Taylor is still awaiting his pathology results, and he hasn’t shared what stage his cancer is. Meanwhile, research into kidney cancer treatment continues to move forward, including for patients whose disease is more advanced.
For people living with advanced kidney cancer, learning that a treatment has stopped working can bring difficult questions about what comes next.
In September 2026, the U.S. Food and Drug Administration (FDA) approved a new targeted drug combination, belzutifan (Welireg) plus lenvatinib (Lenvima), for adults with advanced clear cell renal cell carcinoma whose cancer has progressed after immunotherapy with a PD-1 or PD-L1 inhibitor. Clear cell renal cell carcinoma, named for the pale appearance of its cells under a microscope, is the most common subtype of kidney cancer, making up about 80% of cases in adults.
The two drugs attack cancer from different directions. Belzutifan blocks a protein called HIF-2 alpha, which clear cell kidney cancers can use to adapt to low-oxygen conditions and fuel tumor growth. Lenvatinib blocks growth signals that help tumors build the blood supply they need.
The approval was based on the Phase 3 LITESPARK-011 trial, which enrolled 747 patients and compared the combination with cabozantinib, an established treatment in this setting. Patients receiving belzutifan plus lenvatinib went a median of 14.6 months before their cancer worsened, compared with 10.6 months for those on cabozantinib, and 53% saw their tumors shrink, compared with 40%. However, the trial did not show a statistically significant improvement in overall survival.
“This is a good step moving forward to have another option for our patients, but I would choose this combo for selective patients, perhaps those who have bulky disease and who need a response more quickly, and patients would have to be told about the side effects of anemia,” Dr. Sandy Srinivas, a medical oncologist at Stanford Cancer Center, told SurvivorNet.
The combination can cause serious side effects, including anemia, low oxygen levels, high blood pressure and heart problems, so patients receiving it need close monitoring with regular blood tests, oxygen measurements and blood pressure checks.
Still, for patients facing progression after immunotherapy, having another option matters.
“When a person’s disease progresses after immunotherapy, patients and their families face a difficult moment and important questions about what comes next,” Asya Kogan, Vice President of U.S. & Global Oncology Medical Affairs at Eisai, which makes lenvatinib, told SurvivorNet. “For many, that uncertainty can be one of the hardest parts of the treatment journey.”
A Note on Side Effects and Shared Decision-Making
While these treatments offer hope, they can also come with side effects that impact your body and daily life. That’s why it’s essential to have open, honest conversations with your doctor. Together, you can weigh the risks and benefits, explore supportive care options, and choose a treatment plan that aligns with your values and goals.
What to Know About Von Hippel-Lindau Syndrome
Von Hippel-Lindau syndrome (VHL) is a rare genetic condition linked to many types of benign and malignant tumors, and up to 70% of people with VHL develop kidney cancer, according to UT Southwestern Medical Center. It’s unclear whether Taylor has VHL.
VHL is a rare genetic condition that happens as a result of VHL gene impairment (either gene deletion or mutation) and can cause several types of tumors to grow in different areas of the body. These tumors can be benign or malignant.
Questions For Your Doctor
If you are faced with kidney cancer or you are caring for a loved one who is, here are some questions you can ask your care team to ensure you are getting the best treatment possible.
- What treatment options are available for my specific type and stage of kidney cancer, and how do they differ?
- What are the potential benefits and risks of each treatment, including surgery, targeted therapy, and immunotherapy?
- How will treatment affect my daily life?
- Are there clinical trials that might be appropriate for my situation?
- How will we monitor whether the treatment is working, and what are the next steps if it isn’t?
If you or someone you love is navigating cancer, you don’t have to face every question alone. SurvivorNet’s My Health Questions, an AI-powered tool, can help you find answers to everyday cancer questions, better understand treatment options, and feel more informed along the way.
Contributing: SurvivorNet Staff
Learn more about SurvivorNet's rigorous medical review process.
